Market Currents
Enzon Pharmaceuticals (ENZN) to sell its specialty pharmaceutical business to the sigma-tau...
-
Monday, November 9, 2009, 8:33 AM ETEnzon Pharmaceuticals (ENZN) to sell its specialty pharmaceutical business to the sigma-tau Group for $300M plus another $27M if it hits certain milestones. ENZN will also retain royalties of 5-10%on incremental net sales above a baseline amount. ENZN is halted.
Other date
Latest Articles
